GALNT14-mediated O-glycosylation drives lung adenocarcinoma progression by reducing endogenous reactive oxygen species generation
- 18 October 2024
- journal article
- research article
- Published by Elsevier in Cellular Signalling
- Vol. 124, 111477
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- circPPP2R4 promotes colorectal cancer progression and reduces ROS production through the miR‐646/FOXK1 axisMolecular Carcinogenesis, 2023
- GALNT2, an O-glycosylating enzyme, is a critical regulator of radioresistance of non-small cell lung cancer: evidence from an integrated multi-omics analysisCell Biology and Toxicology, 2023
- RNA-binding protein hnRNP UL1 binds κB sites to attenuate NF-κB-mediated inflammationJournal of Autoimmunity, 2022
- GALNT3 suppresses lung cancer by inhibiting myeloid-derived suppressor cell infiltration and angiogenesis in a TNFR and c-MET pathway-dependent mannerCancer Letters, 2021
- miR-125a-5p impairs the metastatic potential in breast cancer via IP6K1 targetingCancer Letters, 2021
- ST6GalNAc‐I promotes lung cancer metastasis by altering MUC5AC sialylationMolecular Oncology, 2021
- Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?Cancer Cell, 2019
- O‐GlcNAc‐induced nuclear translocation of hnRNP‐K is associated with progression and metastasis of cholangiocarcinomaMolecular Oncology, 2018
- MiR-125a regulates ovarian cancer proliferation and invasion by repressing GALNT14 expressionBiomedicine & Pharmacotherapy, 2016
- Reversal of inflammation‐associated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in nonsmall cell lung cancer cells by wogonin and chrysinInternational Journal of Cancer, 2007